Literature DB >> 33679739

Eosinophilic Esophagitis and Microbiota: State of the Art.

Maurizio Mennini1, Renato Tambucci2, Carla Riccardi1, Francesca Rea2, Paola De Angelis2, Alessandro Fiocchi1, Amal Assa'ad3.   

Abstract

Eosinophilic esophagitis (EoE) is a chronic, food-triggered, immune-mediated disease of the oesophagus, clinically characterized by symptoms referred to oesophagal dysfunction, and histologically defined by an eosinophil productive inflammation of the oesophagal mucosa, among other cell types. The involvement of an adaptive Th2-type response to food antigens in EoE was known since 2000; several cytokines and chemokines promote food-specific responses, during which local production of IgE, but also IgG4 derived from plasma cells in lamina propria of oesophagal mucosa might play an important role. Evidence pointing towards a possible role for the innate immunity in EoE has arisen recently. Together, this evidence gives rise to a potential role that the innate immune system in general, and also the microbial pattern recognition receptors (PRRs) might play in EoE pathogenesis. Among PRRs, Toll-like receptors (TLRs) are type-I transmembrane receptors expressed both on epithelial and lamina propria cells with the capacity to distinguish between pathogen and commensal microbes. As TLRs in the different intestinal epithelia represent the primary mechanism of epithelial recognition of bacteria, this evidence underlines that oesophagal TLR-dependent signaling pathways in EoE support the potential implication of microbiota and the innate immune system in the pathogenesis of this disease. The oesophagal mucosa hosts a resident microbiota, although in a smaller population as compared with other districts of the gastrointestinal tract. Few studies have focused on the composition of the microbiota of the normal oesophagus alone. Still, additional information has come from studies investigating the oesophagal microbiota in disease and including healthy patients as controls. Our review aims to describe all the evidence on the oesophagal and intestinal microbiota in patients with EoE to identify the specific features of dysbiosis in this condition.
Copyright © 2021 Mennini, Tambucci, Riccardi, Rea, De Angelis, Fiocchi and Assa’ad.

Entities:  

Keywords:  dysbiosis; eosinophilic esophagitis; microbiota; probiotics; toll-like receptor

Mesh:

Substances:

Year:  2021        PMID: 33679739      PMCID: PMC7933523          DOI: 10.3389/fimmu.2021.595762

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  83 in total

1.  Esophageal remodeling in pediatric eosinophilic esophagitis.

Authors:  Seema S Aceves; Robert O Newbury; Ranjan Dohil; John F Bastian; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2007-01       Impact factor: 10.793

2.  Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors.

Authors:  Itay Amir; Fred M Konikoff; Michal Oppenheim; Uri Gophna; Elizabeth E Half
Journal:  Environ Microbiol       Date:  2013-10-22       Impact factor: 5.491

Review 3.  Microbiome-wide association studies link dynamic microbial consortia to disease.

Authors:  Jack A Gilbert; Robert A Quinn; Justine Debelius; Zhenjiang Z Xu; James Morton; Neha Garg; Janet K Jansson; Pieter C Dorrestein; Rob Knight
Journal:  Nature       Date:  2016-07-07       Impact factor: 49.962

4.  Expression of toll-like receptors 2 and 3 on esophageal epithelial cell lines and on eosinophils during esophagitis.

Authors:  Daniel J Mulder; David Lobo; Nanette Mak; Christopher J Justinich
Journal:  Dig Dis Sci       Date:  2011-09-30       Impact factor: 3.199

5.  Microbial flora of the normal esophagus.

Authors:  D Gagliardi; S Makihara; P R Corsi; A de T Viana; M V Wiczer; S Nakakubo; L M Mimica
Journal:  Dis Esophagus       Date:  1998-10       Impact factor: 3.429

6.  Megaesophagus microbiota: a qualitative and quantitative analysis.

Authors:  Denis Pajecki; Bruno Zilberstein; Manoel Armando Azevedo dos Santos; Joaō Ari Ubriaco; Alina Guimarães Quintanilha; Ivan Cecconello; Joaquim Gama-Rodrigues
Journal:  J Gastrointest Surg       Date:  2002 Sep-Oct       Impact factor: 3.452

Review 7.  Experimental and analytical tools for studying the human microbiome.

Authors:  Justin Kuczynski; Christian L Lauber; William A Walters; Laura Wegener Parfrey; José C Clemente; Dirk Gevers; Rob Knight
Journal:  Nat Rev Genet       Date:  2011-12-16       Impact factor: 53.242

8.  Lactococcus lactis NCC 2287 alleviates food allergic manifestations in sensitized mice by reducing IL-13 expression specifically in the ileum.

Authors:  Adrian W Zuercher; Marietta Weiss; Sébastien Holvoet; Mireille Moser; Hélène Moussu; Laurence van Overtvelt; Stéphane Horiot; Philippe Moingeon; Sophie Nutten; Guénolée Prioult; Anurag Singh; Annick Mercenier
Journal:  Clin Dev Immunol       Date:  2011-09-22

9.  Association of the maternal microbiome in Japanese pregnant women with the cumulative prevalence of dermatitis in early infancy: A pilot study from the Chiba study of Mother and Child Health birth cohort.

Authors:  Hiromi Tanabe; Kenichi Sakurai; Tamotsu Kato; Yohei Kawasaki; Taiji Nakano; Fumiya Yamaide; Naoko Taguchi-Atarashi; Masahiro Watanabe; Shingo Ochiai; Hiroshi Ohno; Hideoki Fukuoka; Naoki Shimojo; Chisato Mori
Journal:  World Allergy Organ J       Date:  2019-11-01       Impact factor: 4.084

10.  Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma.

Authors:  Ali H Zaidi; Lori A Kelly; Rachael E Kreft; Mark Barlek; Ashten N Omstead; Daisuke Matsui; Natalie H Boyd; Kathryn E Gazarik; Megan I Heit; Laura Nistico; Pashtoon M Kasi; Tracy L Spirk; Barbara Byers; Emily J Lloyd; Rodney J Landreneau; Blair A Jobe
Journal:  BMC Cancer       Date:  2016-02-02       Impact factor: 4.430

View more
  4 in total

Review 1.  Mechanisms and clinical management of eosinophilic oesophagitis: an overview.

Authors:  Luc Biedermann; Alex Straumann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-10-17       Impact factor: 73.082

Review 2.  Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated Diseases.

Authors:  Eva Maria Sturm; Eva Knuplez; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

Review 3.  Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets.

Authors:  Francesca Racca; Gaia Pellegatta; Giuseppe Cataldo; Edoardo Vespa; Elisa Carlani; Corrado Pelaia; Giovanni Paoletti; Maria Rita Messina; Emanuele Nappi; Giorgio Walter Canonica; Alessandro Repici; Enrico Heffler
Journal:  Front Physiol       Date:  2022-01-12       Impact factor: 4.566

Review 4.  Impact of Environmental and Pharmacologic Changes on the Upper Gastrointestinal Microbiome.

Authors:  Joshua Bilello; Ikenna Okereke
Journal:  Biomedicines       Date:  2021-05-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.